BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2016
View Archived Issues
Proteostasis Therapeutics announces pricing of initial public offering
Read More
NF-kappaB inhibition reduces symptoms in mouse model of Rett syndrome
Read More
FKBP5 found to be involved in chronic pain in mouse models
Read More
Novartis patents antibacterial quinolone derivatives
Read More
Nanjing Sanhome reports compounds for the treatment of HCV infections
Read More
Ocular Therapeutix outlines phase III development plans for OTX-TP
Read More
Zilretta meets primary endpoint in pivotal phase III trial in patients with knee osteoarthritis
Read More
Gabra-3 overexpression increases breast cancer metastasis
Read More
Beta cells encapsulated in optimized alginate maintain normoglycemia in mouse model of diabetes
Read More
Galapagos initiates phase II program of GLPG-1837 in cystic fibrosis
Read More
FDA grants breakthrough therapy designation for durvalumab
Read More
Remedy Pharmaceuticals' Cirara obtains two FDA orphan designations
Read More
Phase II study of TNX-201 misses primary endpoints
Read More
Biota Pharmaceuticals' BTA-585 granted FDA fast track designation
Read More
Kevetrin demonstrates safety and tolerability in phase I study in solid tumors
Read More
Apogenix receives grant for immuno-oncology candidate and companion diagnostic
Read More
Lipocine reports topline results from study of LPCN-1107
Read More
Zepatier available in U.S.
Read More
Eisai and Sysmex to codevelop dementia diagnostics
Read More
Sernova receives initial funds for development of severe hemophilia A therapy
Read More
Carmot Therapeutics and Amgen extend research collaboration
Read More
BIND and Synergy to collaborate on Accurin research
Read More